NASDAQ · HSDT
Solana Company
Financial Services · Asset Management
$2.27▼ 1.25% ($0.03)today
As of 11:24 AM ET
Market cap
$132.61M
P/E
-0.07
Volume
112.93K
Shares outstanding
58.39M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 89.96% over the last year. Revenue grew 3,992.2% over the trailing twelve months. Operating margin moved from -4,932.2% to -200.47%. Free cash flow declined 135.48% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -200.47%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Performance
Return analysis
Company profile
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness.
Market multiples
Stock splits
Every 50 shares became 1
Every 15 shares became 1
Every 50 shares became 1
Every 35 shares became 1
Every 5 shares became 1
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Analyst consensus
3
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 17, 2026
Q4 FY26 · EPS est $0.02 · Revenue est $2.65M
View